3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Terminated
1
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
111
Neoplasms
22
Neoplasm Metastasis
17
Brain Neoplasms
15
Breast Neoplasms, Male
13
Head and Neck Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Stomach Neoplasms
5
Glioblastoma
5
Colorectal Neoplasms
5
Prostatic Neoplasms
4
Ovarian Neoplasms
4
Inflammatory Breast Neoplasms
4
Carcinoma, Ovarian Epithelial
4
Salivary Gland Neoplasms
3
Lung Neoplasms
3
Gliosarcoma
3
Glioma
3
Ependymoma
3
Carcinoma, Non-Small-Cell Lung
3
Urinary Bladder Neoplasms
2
Unspecified Adult Solid Tumor, Protocol Specific
2
Solid Tumors
2
Recurrence
2
Osteitis Deformans
2
Oligodendroglioma
2
Neuroma, Acoustic
2
Neurofibromatosis 2
2
Gallbladder Neoplasms
2
Esophageal Neoplasms
2
Interventions
Paclitaxel
6
Carboplatin
6
Radiotherapy
5
Chemotherapy, Adjuvant
5
Cyclophosphamide
4
Trastuzumab
3
Tamoxifen
3
Letrozole
3
Doxorubicin
3
Brachytherapy
3
Albumin-Bound Paclitaxel
3
130-nm albumin-bound paclitaxel
3
pertuzumab
2
Surgical Procedures, Operative
2
Radiotherapy, Conformal
2
Magnetic Resonance Spectroscopy
2
Epirubicin
2
talimogene laherparepvec
1
sargramostim
1
palbociclib
1
ferric carboxymaltose
1
atezolizumab
1
atamestane
1
aldesleukin
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
VPS Coriolus versicolor extract
1
Toremifene
1
Thiotepa
1
Therapeutics
1
Reverse Transcriptase Polymerase Chain Reaction
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Carcinoma, Ductal, Breast
×
Lapatinib
×
Clear all
NCT01426880
2016-02-15
GeparSixto
GBG Forschungs GmbH
Phase 2/3
Completed
595 enrolled